XML 34 R56.htm IDEA: XBRL DOCUMENT v2.4.1.9
Collaboration Agreements (Details) (USD $)
3 Months Ended 0 Months Ended 1 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 16, 2014
Feb. 28, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaborative Arrangement, Milestone Payment $ 1,000,000mdco_CollaborativeArrangementMilestonePayment $ 0mdco_CollaborativeArrangementMilestonePayment    
SciClone [Member] | Collaborative Arrangement, Co-promotion [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaborative Agreement, Milestone Payment Received     50,500,000mdco_CollaborativeAgreementMilestonePaymentReceived
/ us-gaap_CounterpartyNameAxis
= mdco_SciCloneMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementCopromotionMember
 
Co-Pomotion Income 7,800,000mdco_CoPomotionIncome
/ us-gaap_CounterpartyNameAxis
= mdco_SciCloneMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementCopromotionMember
     
Alnylam Pharmaceuticals, Inc. [Member] | Collaborative Arrangement [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Initial payment       25,000,000mdco_CollaborativeArrangementCashPayment
/ us-gaap_CounterpartyNameAxis
= mdco_AlnylamPharmaceuticalsInc.Member
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement, Milestone Payment       10,000,000mdco_CollaborativeArrangementMilestonePayment
/ us-gaap_CounterpartyNameAxis
= mdco_AlnylamPharmaceuticalsInc.Member
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Maximum payment for success-based development and commercialization milestones       $ 170,000,000mdco_CollaborativeArrangementPaymentforMilestoneMet1
/ us-gaap_CounterpartyNameAxis
= mdco_AlnylamPharmaceuticalsInc.Member
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember